COVAX Advance Market Commitment (AMC)
Rich countries corner nearly 51% supply of five major COVID-19 vaccine candidates: Oxfam
According to a recent study by Oxfam International, wealthy nations, which account for nearly 13% of the global population, have cornered a lion’s share of supply deals for vaccine candidates in phase-3 of the clinical trials
